Green Thumb Industries (GTBIF) Receivables - Net (2019 - 2026)
Green Thumb Industries' (GTBIF) quarterly Receivables - Net came in at $51.9 million in Q1 2026, up 9.35% YoY from $47.5 million in Q1 2025, and up 1.22% on a QoQ basis from $51.3 million in Q4 2025.
Green Thumb Industries (GTBIF) Receivables - Net (2019 - 2026) Analysis & Trends
Green Thumb Industries (GTBIF) has 8 years of Receivables - Net data on file, last reported at $51.9 million in Q1 2026.
- Quarterly Receivables - Net rose 9.35% year-over-year to $51.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $51.9 million (up 9.35% YoY) and the FY2025 annual result came in at $51.3 million, down 2.96% from the prior year.
- Receivables - Net grew to $51.9 million in Q1 2026, from $51.3 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $52.8 million in Q4 2024 to a low of $25.7 million in Q2 2022.
- A 5-year average of $42.3 million and a median of $46.4 million in 2025 frame the typical range for Receivables - Net.
- Annual changes were most pronounced in 2024 — Receivables - Net surged 68.4% — and 2025, when it declined 9.05%.
- Tracing GTBIF's Receivables - Net over 5 years: stood at $31.0 million in 2022, then surged by 38.74% to $43.0 million in 2023, then increased by 22.93% to $52.8 million in 2024, then retreated by 2.96% to $51.3 million in 2025, then climbed by 1.22% to $51.9 million in 2026.
- The last three Receivables - Net figures came in at $51.9 million (Q1 2026), $51.3 million (Q4 2025), and $51.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Green Thumb Industries | 1.65 Bn | 1.37 Bn | 137.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 53.09 Mn |
| Jun 30, 2026 | 53.09 Mn |
| Mar 31, 2026 | 51.90 Mn |
| Mar 31, 2026 | 51.90 Mn |
| Dec 31, 2025 | 51.27 Mn |
| Dec 31, 2025 | 51.27 Mn |
| Sep 30, 2025 | 51.39 Mn |
| Sep 30, 2025 | 51.39 Mn |
| Jun 30, 2025 | 46.45 Mn |
| Jun 30, 2025 | 46.45 Mn |
| Mar 31, 2025 | 47.46 Mn |
| Mar 31, 2025 | 47.46 Mn |
| Dec 31, 2024 | 52.83 Mn |
| Dec 31, 2024 | 52.83 Mn |
| Sep 30, 2024 | 48.96 Mn |
| Sep 30, 2024 | 48.96 Mn |
| Jun 30, 2024 | 49.34 Mn |
| Jun 30, 2024 | 49.34 Mn |
| Mar 31, 2024 | 52.18 Mn |
| Mar 31, 2024 | 52.18 Mn |